arrow
N

Nadia Stucchi

istituto di ricerche farmacologiche mario negri irccs
H指数:18
被引数:1,772

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy

富尔扎尔塔单抗在利妥昔单抗耐药的原发性膜性肾病中的前瞻性队列研究

2026-03-120
OAAI
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

肾小球阻力预测无明显肾病的2型糖尿病患者的长期GFR下降: DEMAND试验的纵向亚组分析

2021-10-143
PREAI
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial
2019-08-0144
PREAI
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial
2019-02-2219
PREAI
Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial
2016-09-1576
OAAI
The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

无法准确估计2型糖尿病患者的GFR和GFR下降

2013-07-01132
OAAI
Effects of Add-on Fluvastatin Therapy in Patients with Chronic Proteinuric Nephropathy on Dual Renin-Angiotensin System Blockade: The ESPLANADE Trial
2010-11-0136
OAAI